| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 1.26e-04 | 103 | 94 | 5 | GO:0004725 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 2.71e-04 | 189 | 94 | 6 | GO:0004721 | |
| GeneOntologyBiologicalProcess | dense core granule docking | 2.01e-05 | 2 | 93 | 2 | GO:0061790 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | AKAP6 UNC13B CACNA1D RELN FFAR3 GPR42 CRTC1 SHANK3 PTPN3 KCNG1 KDR | 4.30e-05 | 559 | 93 | 11 | GO:0042391 |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to non-antigenic stimulus | 6.02e-05 | 3 | 93 | 2 | GO:0002879 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to non-antigenic stimulus | 1.20e-04 | 4 | 93 | 2 | GO:0002877 | |
| GeneOntologyBiologicalProcess | dense core granule priming | 1.20e-04 | 4 | 93 | 2 | GO:0061789 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system process | 1.27e-04 | 57 | 93 | 4 | GO:0031646 | |
| GeneOntologyBiologicalProcess | regulation of nervous system process | 1.42e-04 | 175 | 93 | 6 | GO:0031644 | |
| GeneOntologyBiologicalProcess | positive regulation of AMPA receptor activity | 1.99e-04 | 5 | 93 | 2 | GO:2000969 | |
| GeneOntologyBiologicalProcess | positive regulation of glutamate receptor signaling pathway | 1.99e-04 | 5 | 93 | 2 | GO:1900451 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to non-antigenic stimulus | 1.99e-04 | 5 | 93 | 2 | GO:0002525 | |
| GeneOntologyBiologicalProcess | neuron development | RELN GAK IRX5 FAT3 NR4A2 LMTK2 PCDHAC2 CRTC1 ITGA1 CSMD3 SHANK3 TENM4 KDR ALCAM CDH4 UNC13A ANKS1A | 2.63e-04 | 1463 | 93 | 17 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPS8 RELN SHROOM3 FAT3 SPTA1 NR4A2 LMTK2 PCDHAC2 ITGA1 SHANK3 ST14 KDR ALCAM CDH4 UNC13A | 2.78e-04 | 1194 | 93 | 15 | GO:0000902 |
| GeneOntologyBiologicalProcess | NMDA glutamate receptor clustering | 2.98e-04 | 6 | 93 | 2 | GO:0097114 | |
| GeneOntologyBiologicalProcess | positive regulation of neuronal action potential | 2.98e-04 | 6 | 93 | 2 | GO:1904457 | |
| GeneOntologyBiologicalProcess | action potential | 3.00e-04 | 201 | 93 | 6 | GO:0001508 | |
| Domain | - | 6.54e-06 | 92 | 93 | 6 | 3.90.190.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.00e-05 | 99 | 93 | 6 | IPR029021 | |
| Domain | NBPF_dom | 1.92e-05 | 11 | 93 | 3 | IPR010630 | |
| Domain | NBPF | 1.92e-05 | 11 | 93 | 3 | PS51316 | |
| Domain | DUF1220 | 1.92e-05 | 11 | 93 | 3 | PF06758 | |
| Domain | Unc-13 | 7.33e-05 | 3 | 93 | 2 | IPR027080 | |
| Domain | ConA-like_dom | 1.12e-04 | 219 | 93 | 7 | IPR013320 | |
| Domain | GPR40-rel_orph | 1.46e-04 | 4 | 93 | 2 | IPR013312 | |
| Domain | PTPc_motif | 2.13e-04 | 59 | 93 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 2.13e-04 | 59 | 93 | 4 | IPR003595 | |
| Domain | Munc13_dom-2 | 2.43e-04 | 5 | 93 | 2 | IPR014772 | |
| Domain | Membr_traf_MHD | 2.43e-04 | 5 | 93 | 2 | PF10540 | |
| Domain | MHD2 | 2.43e-04 | 5 | 93 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 2.43e-04 | 5 | 93 | 2 | IPR019558 | |
| Domain | DUF1041 | 2.43e-04 | 5 | 93 | 2 | SM01145 | |
| Domain | Tyr_Pase_AS | 4.82e-04 | 73 | 93 | 4 | IPR016130 | |
| Domain | DUF1041 | 5.07e-04 | 7 | 93 | 2 | PF06292 | |
| Domain | Munc13_1 | 5.07e-04 | 7 | 93 | 2 | IPR014770 | |
| Domain | CAPS_dom | 5.07e-04 | 7 | 93 | 2 | IPR010439 | |
| Domain | MHD1 | 5.07e-04 | 7 | 93 | 2 | PS51258 | |
| Domain | - | 6.74e-04 | 8 | 93 | 2 | 3.30.70.340 | |
| Domain | PTEN_C2 | 6.74e-04 | 8 | 93 | 2 | SM01326 | |
| Domain | PTEN_C2 | 6.74e-04 | 8 | 93 | 2 | PF10409 | |
| Domain | PTB | 6.74e-04 | 8 | 93 | 2 | PF08416 | |
| Domain | PTB | 6.74e-04 | 8 | 93 | 2 | IPR013625 | |
| Domain | Ubox | 6.74e-04 | 8 | 93 | 2 | SM00504 | |
| Domain | C2_TENSIN | 6.74e-04 | 8 | 93 | 2 | PS51182 | |
| Domain | Tensin_lipid_phosphatase_dom | 6.74e-04 | 8 | 93 | 2 | IPR029023 | |
| Domain | Propep_M14 | 6.74e-04 | 8 | 93 | 2 | PF02244 | |
| Domain | Tensin_C2-dom | 6.74e-04 | 8 | 93 | 2 | IPR014020 | |
| Domain | M14A_act_pep | 6.74e-04 | 8 | 93 | 2 | IPR003146 | |
| Domain | PDZ | 6.97e-04 | 141 | 93 | 5 | PF00595 | |
| Domain | PTPc | 7.58e-04 | 36 | 93 | 3 | SM00194 | |
| Domain | PPASE_TENSIN | 8.63e-04 | 9 | 93 | 2 | PS51181 | |
| Domain | DUF1220 | 8.63e-04 | 9 | 93 | 2 | SM01148 | |
| Domain | PDZ | 8.67e-04 | 148 | 93 | 5 | SM00228 | |
| Domain | TYR_PHOSPHATASE_1 | 8.96e-04 | 86 | 93 | 4 | PS00383 | |
| Domain | - | 9.21e-04 | 150 | 93 | 5 | 2.30.42.10 | |
| Domain | TYR_PHOSPHATASE_2 | 9.35e-04 | 87 | 93 | 4 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 9.35e-04 | 87 | 93 | 4 | IPR000387 | |
| Domain | PDZ | 9.49e-04 | 151 | 93 | 5 | PS50106 | |
| Domain | TYR_PHOSPHATASE_PTP | 9.59e-04 | 39 | 93 | 3 | PS50055 | |
| Domain | PDZ | 9.77e-04 | 152 | 93 | 5 | IPR001478 | |
| Domain | PTB | 1.03e-03 | 40 | 93 | 3 | SM00462 | |
| Domain | Ubox_domain | 1.08e-03 | 10 | 93 | 2 | IPR003613 | |
| Domain | PTX | 1.08e-03 | 10 | 93 | 2 | SM00159 | |
| Domain | PTPase_domain | 1.11e-03 | 41 | 93 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 1.11e-03 | 41 | 93 | 3 | PF00102 | |
| Domain | PTB/PI_dom | 1.11e-03 | 41 | 93 | 3 | IPR006020 | |
| Domain | Pentaxin-related | 1.31e-03 | 11 | 93 | 2 | IPR001759 | |
| Domain | Pentaxin | 1.31e-03 | 11 | 93 | 2 | PF00354 | |
| Domain | C2_dom | 1.37e-03 | 164 | 93 | 5 | IPR000008 | |
| Domain | PRY | 1.76e-03 | 48 | 93 | 3 | SM00589 | |
| Domain | PRY | 1.76e-03 | 48 | 93 | 3 | IPR006574 | |
| Domain | Cadherin_CS | 2.15e-03 | 109 | 93 | 4 | IPR020894 | |
| Domain | CADHERIN_1 | 2.45e-03 | 113 | 93 | 4 | PS00232 | |
| Domain | Cadherin | 2.45e-03 | 113 | 93 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 2.53e-03 | 114 | 93 | 4 | PS50268 | |
| Domain | - | 2.53e-03 | 114 | 93 | 4 | 2.60.40.60 | |
| Domain | CA | 2.61e-03 | 115 | 93 | 4 | SM00112 | |
| Domain | Cadherin-like | 2.70e-03 | 116 | 93 | 4 | IPR015919 | |
| Domain | VWA | 2.74e-03 | 56 | 93 | 3 | PF00092 | |
| Domain | Cadherin | 2.87e-03 | 118 | 93 | 4 | IPR002126 | |
| Domain | Propept_inh | 3.18e-03 | 17 | 93 | 2 | IPR009020 | |
| Domain | EGF_extracell | 3.33e-03 | 60 | 93 | 3 | IPR013111 | |
| Domain | EGF_2 | 3.33e-03 | 60 | 93 | 3 | PF07974 | |
| Domain | Zn_pept | 3.56e-03 | 18 | 93 | 2 | SM00631 | |
| Domain | CARBOXYPEPT_ZN_2 | 3.97e-03 | 19 | 93 | 2 | PS00133 | |
| Domain | CARBOXYPEPT_ZN_1 | 4.40e-03 | 20 | 93 | 2 | PS00132 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.47e-05 | 85 | 68 | 5 | M16441 | |
| Pubmed | 2.87e-11 | 21 | 102 | 6 | 16079250 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 1.44e-08 | 10 | 102 | 4 | 22973535 | |
| Pubmed | NBPF8 COL6A3 NBPF12 CPA5 APOB NBPF11 CSMD3 NBPF9 NBPF10 PRPF19 IGSF1 NBPF14 | 3.79e-08 | 513 | 102 | 12 | 25798074 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 SHROOM3 LMTK2 SIK1 CRTC1 PARD3B SORBS1 TAB3 ARFGEF3 PTPN3 PIK3C2B NHS PATJ ANKS1A | 2.32e-07 | 861 | 102 | 14 | 36931259 |
| Pubmed | AKAP6 RALGAPA1 SHROOM3 LMTK2 CRTC1 USP38 DDHD1 HPS4 SCAF11 IGSF1 ANKS1A | 4.66e-07 | 529 | 102 | 11 | 14621295 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 25637492 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 30478340 | ||
| Pubmed | Intestinal FFA3 mediates obesogenic effects in mice on a Western diet. | 8.52e-06 | 2 | 102 | 2 | 35858247 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 12871971 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 22506074 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17561838 | ||
| Pubmed | Heterodimerization of Munc13 C2A domain with RIM regulates synaptic vesicle docking and priming. | 8.52e-06 | 2 | 102 | 2 | 28489077 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 24748202 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 36362376 | ||
| Pubmed | Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. | 8.52e-06 | 2 | 102 | 2 | 10440375 | |
| Pubmed | Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin. | 8.52e-06 | 2 | 102 | 2 | 22066784 | |
| Pubmed | Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses. | 8.52e-06 | 2 | 102 | 2 | 32187536 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 22814762 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 20399779 | ||
| Pubmed | Formation and Maintenance of Functional Spines in the Absence of Presynaptic Glutamate Release. | 8.52e-06 | 2 | 102 | 2 | 28426965 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23770256 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23110765 | ||
| Pubmed | The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation. | 8.52e-06 | 2 | 102 | 2 | 26522986 | |
| Pubmed | Phospholipase D and mTORC1: nutrients are what bring them together. | 8.52e-06 | 2 | 102 | 2 | 22457329 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 34669330 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 27664183 | ||
| Pubmed | Calcium-Independent Exo-endocytosis Coupling at Small Central Synapses. | 8.52e-06 | 2 | 102 | 2 | 31851910 | |
| Pubmed | Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. | 8.52e-06 | 2 | 102 | 2 | 11832228 | |
| Pubmed | Munc13 controls the location and efficiency of dense-core vesicle release in neurons. | 8.52e-06 | 2 | 102 | 2 | 23229896 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 37019194 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 38040866 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 35408893 | ||
| Pubmed | FFAR3 modulates insulin secretion and global gene expression in mouse islets. | 8.52e-06 | 2 | 102 | 2 | 26091414 | |
| Pubmed | Integrin alpha1 localization in murine central and peripheral nervous system. | 8.52e-06 | 2 | 102 | 2 | 9603370 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 12070347 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 27550964 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 32073900 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23070049 | ||
| Pubmed | Molecular Mechanisms of Synaptic Vesicle Priming by Munc13 and Munc18. | 8.52e-06 | 2 | 102 | 2 | 28772123 | |
| Pubmed | Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion. | 8.52e-06 | 2 | 102 | 2 | 17267576 | |
| Pubmed | Sequence polymorphisms provide a common consensus sequence for GPR41 and GPR42. | 8.52e-06 | 2 | 102 | 2 | 19630535 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 35613050 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 29408765 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 36434056 | ||
| Pubmed | Membrane bridging by Munc13-1 is crucial for neurotransmitter release. | 8.52e-06 | 2 | 102 | 2 | 30816091 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 30058071 | ||
| Pubmed | A common molecular basis for membrane docking and functional priming of synaptic vesicles. | 8.52e-06 | 2 | 102 | 2 | 19558619 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18701688 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 14722361 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 11792326 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 26260360 | ||
| Pubmed | 1.13e-05 | 47 | 102 | 4 | 15172686 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 1.14e-05 | 170 | 102 | 6 | 23314748 | |
| Pubmed | RALGAPA1 ELOA EYA4 LMTK2 PTPN22 PTPRT TAB3 PTPN3 SUN2 DUSP16 NHS PRPF19 TNS1 | 1.24e-05 | 1049 | 102 | 13 | 27880917 | |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 1.31e-05 | 102 | 102 | 5 | 15778465 | |
| Pubmed | Transcription Factors Sp8 and Sp9 Coordinately Regulate Olfactory Bulb Interneuron Development. | 2.29e-05 | 19 | 102 | 3 | 28981617 | |
| Pubmed | Salt-inducible kinase 1 regulates bone anabolism via the CRTC1-CREB-Id1 axis. | 2.55e-05 | 3 | 102 | 2 | 31672960 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 12496283 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 23665276 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 34210970 | ||
| Pubmed | Dietary short-chain fatty acid intake improves the hepatic metabolic condition via FFAR3. | 2.55e-05 | 3 | 102 | 2 | 31719611 | |
| Pubmed | IL-12 and IL-15 induce the expression of CXCR6 and CD49a on peripheral natural killer cells. | 2.55e-05 | 3 | 102 | 2 | 28952190 | |
| Pubmed | Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes. | 2.55e-05 | 3 | 102 | 2 | 25581519 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 33105896 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 31272808 | ||
| Pubmed | TORC-SIK cascade regulates CREB activity through the basic leucine zipper domain. | 2.55e-05 | 3 | 102 | 2 | 17565599 | |
| Pubmed | GPR41 and GPR43 regulate CD8+ T cell priming during herpes simplex virus type 1 infection. | 2.55e-05 | 3 | 102 | 2 | 38524121 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 22673524 | ||
| Pubmed | Munc13- and SNAP25-dependent molecular bridges play a key role in synaptic vesicle priming. | 2.55e-05 | 3 | 102 | 2 | 37343100 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 23658173 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 26404905 | ||
| Pubmed | Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. | 2.55e-05 | 3 | 102 | 2 | 16123168 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 22493486 | ||
| Pubmed | The CRTC1-SIK1 pathway regulates entrainment of the circadian clock. | 2.55e-05 | 3 | 102 | 2 | 23993098 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 17639022 | ||
| Pubmed | Embryonic stem cell-derived CD166+ precursors develop into fully functional sinoatrial-like cells. | 2.55e-05 | 3 | 102 | 2 | 23753573 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 23066016 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 22190648 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 23885020 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 29768180 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 18931303 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 22966208 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 7734734 | ||
| Pubmed | Abnormalities in microbiota/butyrate/FFAR3 signaling in aging gut impair brain function. | 2.55e-05 | 3 | 102 | 2 | 38329121 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 15988013 | ||
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 2.62e-05 | 58 | 102 | 4 | 30377227 | |
| Pubmed | 3.62e-05 | 22 | 102 | 3 | 35245678 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 4.69e-05 | 569 | 102 | 9 | 30639242 | |
| Pubmed | Transient, phorbol ester-induced DOC2-Munc13 interactions in vivo. | 5.09e-05 | 4 | 102 | 2 | 10488064 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 23401498 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 9344866 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 15132990 | ||
| Pubmed | Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. | 5.09e-05 | 4 | 102 | 2 | 16817901 | |
| Pubmed | Mutation screening and imprinting analysis of four candidate genes for autism in the 7q32 region. | 5.09e-05 | 4 | 102 | 2 | 11920156 | |
| Pubmed | Fbxo45, a novel ubiquitin ligase, regulates synaptic activity. | 5.09e-05 | 4 | 102 | 2 | 19996097 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 21518883 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 15684720 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 29644622 | ||
| Pubmed | Munc13-1-mediated vesicle priming contributes to secretory amyloid precursor protein processing. | 5.09e-05 | 4 | 102 | 2 | 15123597 | |
| Pubmed | ELKS1 localizes the synaptic vesicle priming protein bMunc13-2 to a specific subset of active zones. | 5.09e-05 | 4 | 102 | 2 | 28264913 | |
| Interaction | YWHAG interactions | RALGAPA1 SHROOM3 ZBTB33 LMTK2 SIK1 CRTC1 PARD3B TRIM21 SORBS1 SHANK3 TAB3 PTPN3 PIK3C2B DUSP16 NHS PRPF19 KDR SCAF11 PATJ THRAP3 ANKS1A | 5.57e-07 | 1248 | 99 | 21 | int:YWHAG |
| Interaction | VASP interactions | 1.45e-05 | 294 | 99 | 9 | int:VASP | |
| Interaction | YWHAZ interactions | RALGAPA1 ELOA SHROOM3 ZBTB33 SPTA1 SIK1 CRTC1 PARD3B TRIM21 SORBS1 SHANK3 TAB3 PTPN3 PIK3C2B DUSP16 NHS SCAF11 TNS1 ANKS1A | 1.96e-05 | 1319 | 99 | 19 | int:YWHAZ |
| Interaction | NEK4 interactions | NBPF8 COL6A3 NBPF12 CPA5 APOB NBPF11 CSMD3 NBPF9 NBPF10 PRPF19 IGSF1 NBPF14 | 2.82e-05 | 582 | 99 | 12 | int:NEK4 |
| Interaction | YWHAE interactions | RALGAPA1 ELOA SHROOM3 ZBTB33 SIK1 CRTC1 PARD3B TRIM21 SORBS1 SHANK3 TAB3 PTPN3 PIK3C2B DUSP16 NHS TTC17 SCAF11 ANKS1A | 3.60e-05 | 1256 | 99 | 18 | int:YWHAE |
| Cytoband | 1q21.1 | 2.87e-07 | 62 | 102 | 5 | 1q21.1 | |
| GeneFamily | Neuroblastoma breakpoint family | 5.88e-12 | 23 | 80 | 7 | 662 | |
| GeneFamily | UNC13 homologs | 1.15e-04 | 4 | 80 | 2 | 836 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 5.32e-04 | 8 | 80 | 2 | 837 | |
| GeneFamily | PDZ domain containing | 5.69e-04 | 152 | 80 | 5 | 1220 | |
| GeneFamily | Collagens | 1.10e-03 | 46 | 80 | 3 | 490 | |
| GeneFamily | Immunoglobulin like domain containing | 1.66e-03 | 193 | 80 | 5 | 594 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 2.83e-03 | 18 | 80 | 2 | 812 | |
| GeneFamily | Carboxypeptidases | 3.84e-03 | 21 | 80 | 2 | 1321 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 5.92e-03 | 163 | 80 | 4 | 590 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP | 1.12e-05 | 198 | 100 | 7 | M5293 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_DC_UP | 1.19e-05 | 200 | 100 | 7 | M6271 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.33e-09 | 181 | 102 | 8 | 47dce04db3392333eb2f7b9b24c32e6740d2d02f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.33e-09 | 181 | 102 | 8 | 19103221c3a5a16b16378348004b2c50caee4f01 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-08 | 184 | 102 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-08 | 184 | 102 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-08 | 184 | 102 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.20e-08 | 187 | 102 | 8 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.33e-07 | 170 | 102 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.38e-07 | 171 | 102 | 7 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-07 | 176 | 102 | 7 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-07 | 176 | 102 | 7 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.27e-07 | 184 | 102 | 7 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.27e-07 | 184 | 102 | 7 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.36e-07 | 185 | 102 | 7 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-07 | 186 | 102 | 7 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.63e-07 | 188 | 102 | 7 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.63e-07 | 188 | 102 | 7 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.25e-07 | 194 | 102 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.36e-07 | 195 | 102 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.36e-07 | 195 | 102 | 7 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.60e-07 | 197 | 102 | 7 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 11.5-Airway-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 3.60e-07 | 197 | 102 | 7 | e671af1b69566d97afe97f1a959a07b6f4c05620 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.73e-07 | 198 | 102 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.99e-07 | 200 | 102 | 7 | 47791c93d03ee17c1ce17e27f075be4fc6f2590e | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.99e-07 | 200 | 102 | 7 | f75d95376a340d467c4392b872b2a2dbdd184556 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.99e-07 | 200 | 102 | 7 | fae26560ba3b0b638b6bcf92f05330824b31d21b | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.68e-06 | 157 | 102 | 6 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.40e-06 | 167 | 102 | 6 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.57e-06 | 169 | 102 | 6 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.94e-06 | 173 | 102 | 6 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 174 | 102 | 6 | 28ec25767bbd4fd898738f9f4d2b585dc91b5adf | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 3.04e-06 | 174 | 102 | 6 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.69e-06 | 180 | 102 | 6 | c12c1cc206f7e63e5722471bd3eb84caddb84129 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.69e-06 | 180 | 102 | 6 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.69e-06 | 180 | 102 | 6 | d8135f73a89b97168f2048258f4648e23536ece4 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.69e-06 | 180 | 102 | 6 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 3.69e-06 | 180 | 102 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.81e-06 | 181 | 102 | 6 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.81e-06 | 181 | 102 | 6 | 03a303cd2f366f09c18b118bbba6f5e3f95ad56c | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 3.81e-06 | 181 | 102 | 6 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.94e-06 | 182 | 102 | 6 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-06 | 183 | 102 | 6 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.19e-06 | 184 | 102 | 6 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.19e-06 | 184 | 102 | 6 | d0c212a8fbaad24597a84018442b25c61c17ea58 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.33e-06 | 185 | 102 | 6 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.33e-06 | 185 | 102 | 6 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.33e-06 | 185 | 102 | 6 | 0094f9baddb20214d2a2c166f1637d1a9cf1169a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.46e-06 | 186 | 102 | 6 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 4.60e-06 | 187 | 102 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.60e-06 | 187 | 102 | 6 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.74e-06 | 188 | 102 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.74e-06 | 188 | 102 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.74e-06 | 188 | 102 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 4.74e-06 | 188 | 102 | 6 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.89e-06 | 189 | 102 | 6 | 0d18ea72bd58d32a8ab9a61cf97f5786642f804b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.89e-06 | 189 | 102 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.89e-06 | 189 | 102 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 4.89e-06 | 189 | 102 | 6 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.04e-06 | 190 | 102 | 6 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-06 | 191 | 102 | 6 | 1caf726bd07fdca389e678fc16304a6ef1790423 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 5.19e-06 | 191 | 102 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-06 | 191 | 102 | 6 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-06 | 191 | 102 | 6 | 3d60c46bced2984c27a1fcf2910bc38b31fb0148 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.19e-06 | 191 | 102 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-06 | 192 | 102 | 6 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.35e-06 | 192 | 102 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-06 | 192 | 102 | 6 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 5.35e-06 | 192 | 102 | 6 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.51e-06 | 193 | 102 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 5.51e-06 | 193 | 102 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-06 | 193 | 102 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.51e-06 | 193 | 102 | 6 | bd0027fa97de41ae22ff64a61c8e217496f122ca | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.51e-06 | 193 | 102 | 6 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.68e-06 | 194 | 102 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.68e-06 | 194 | 102 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.68e-06 | 194 | 102 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 5.68e-06 | 194 | 102 | 6 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.85e-06 | 195 | 102 | 6 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | facs-GAT-Fat-3m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-06 | 196 | 102 | 6 | b6cc1f466d45479764080d34b1daeb8243a5a9f3 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-06 | 196 | 102 | 6 | ede6104cdfa4ee5287efcca9bbc36677cbf7a8d8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 196 | 102 | 6 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-06 | 196 | 102 | 6 | 039044ab28c53391c34d8226fb8cf78549e63ef4 | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.02e-06 | 196 | 102 | 6 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.02e-06 | 196 | 102 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-06 | 197 | 102 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-06 | 197 | 102 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.20e-06 | 197 | 102 | 6 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-06 | 197 | 102 | 6 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.20e-06 | 197 | 102 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.20e-06 | 197 | 102 | 6 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | wk_15-18-Epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.38e-06 | 198 | 102 | 6 | 12bbe77c3d68bf1e545949dbb1eb49ed3641de3d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.38e-06 | 198 | 102 | 6 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.38e-06 | 198 | 102 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.38e-06 | 198 | 102 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.38e-06 | 198 | 102 | 6 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 6.57e-06 | 199 | 102 | 6 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | Bronchial-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.57e-06 | 199 | 102 | 6 | 36a230b80096455df26c2e2c8c05fd6b231508c5 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 6.57e-06 | 199 | 102 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.57e-06 | 199 | 102 | 6 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.76e-06 | 200 | 102 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.76e-06 | 200 | 102 | 6 | 2bc7f462a551292de2501028164573935232f899 | |
| Drug | Pesticides | 2.81e-07 | 150 | 98 | 8 | ctd:D010575 | |
| Drug | 5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 1.97e-06 | 194 | 98 | 8 | 862_UP | |
| Disease | schizophrenia (implicated_via_orthology) | 2.76e-06 | 68 | 95 | 5 | DOID:5419 (implicated_via_orthology) | |
| Disease | methadone dose measurement | 4.87e-05 | 62 | 95 | 4 | EFO_0007907 | |
| Disease | mean platelet volume | PCDHGA6 SPTA1 PAQR8 CRTC1 SORBS1 SHANK3 SVEP1 FAH SP8 DDHD1 MICA ANKS1A | 1.07e-04 | 1020 | 95 | 12 | EFO_0004584 |
| Disease | coronary artery disease | COL6A3 SHROOM3 APOB ITGA1 SVEP1 AP4E1 SP8 SCAF11 ALCAM KDF1 TNS1 UNC13A ANKS1A | 1.17e-04 | 1194 | 95 | 13 | EFO_0001645 |
| Disease | Manic | 1.20e-04 | 78 | 95 | 4 | C0338831 | |
| Disease | response to angiotensin receptor blocker | 1.23e-04 | 30 | 95 | 3 | EFO_0010735 | |
| Disease | Graves disease | 1.39e-04 | 81 | 95 | 4 | EFO_0004237 | |
| Disease | otosclerosis | 1.39e-04 | 81 | 95 | 4 | EFO_0004213 | |
| Disease | persistent Staphylococcus aureus carrier status | 1.53e-04 | 6 | 95 | 2 | EFO_0007757 | |
| Disease | visceral adipose tissue measurement | 1.66e-04 | 481 | 95 | 8 | EFO_0004765 | |
| Disease | chronic obstructive pulmonary disease | 3.82e-04 | 688 | 95 | 9 | EFO_0000341 | |
| Disease | Colorectal Carcinoma | 4.41e-04 | 702 | 95 | 9 | C0009402 | |
| Disease | diffuse plaque measurement | 7.63e-04 | 758 | 95 | 9 | EFO_0010699 | |
| Disease | cortical surface area measurement | RELN SHROOM3 FAT3 PARD3B SVEP1 SP8 USP38 MICA ALCAM PAX7 TNS1 ANKS1A | 1.27e-03 | 1345 | 95 | 12 | EFO_0010736 |
| Disease | Muscle hypotonia | 1.35e-03 | 17 | 95 | 2 | C0026827 | |
| Disease | autoimmune thyroid disease, type 1 diabetes mellitus | 1.52e-03 | 18 | 95 | 2 | EFO_0006812, MONDO_0005147 | |
| Disease | Manic Disorder | 1.58e-03 | 71 | 95 | 3 | C0024713 | |
| Disease | diet measurement, HOMA-B | 1.69e-03 | 19 | 95 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | hemifacial microsomia | 1.69e-03 | 19 | 95 | 2 | MONDO_0015398 | |
| Disease | C-reactive protein measurement | AKAP6 APOB ITGA1 PTPN3 ZNF655 SCAF11 VSIG8 PATJ KDF1 CDH4 ANKS1A | 1.72e-03 | 1206 | 95 | 11 | EFO_0004458 |
| Disease | visual cortical surface area measurement | 1.88e-03 | 20 | 95 | 2 | EFO_0004771 | |
| Disease | Autoimmune Hepatitis | 2.07e-03 | 21 | 95 | 2 | EFO_0005676 | |
| Disease | vital capacity | COL6A3 SHROOM3 EYA4 NBPF12 APOB SVEP1 PIK3C2B KDR PATJ TNS1 ANKS1A | 2.08e-03 | 1236 | 95 | 11 | EFO_0004312 |
| Disease | Depression, Bipolar | 2.14e-03 | 79 | 95 | 3 | C0005587 | |
| Disease | Mood Disorders | 2.16e-03 | 168 | 95 | 4 | C0525045 | |
| Disease | body weight | AKAP6 UNC13B RALGAPA1 RELN NR4A2 CRTC1 PARD3B PTPRT SP8 MICA PATJ | 2.43e-03 | 1261 | 95 | 11 | EFO_0004338 |
| Disease | Autism Spectrum Disorders | 2.64e-03 | 85 | 95 | 3 | C1510586 | |
| Disease | alpha-2-macroglobulin receptor-associated protein measurement | 2.70e-03 | 24 | 95 | 2 | EFO_0008021 | |
| Disease | cortical thickness | 3.11e-03 | 1113 | 95 | 10 | EFO_0004840 | |
| Disease | major depressive disorder, COVID-19 | 3.17e-03 | 26 | 95 | 2 | MONDO_0002009, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AYYAHTTASTNVSAS | 906 | Q9UPW8 | |
| SSDSRANADGYSLYD | 176 | Q6UXE8 | |
| SSSGHYDSVYSKQFQ | 341 | Q9NP73 | |
| YHEDYGFSSFNDSSQ | 6 | O00574 | |
| FSTTHETSLYFHSDY | 2191 | Q7Z407 | |
| TYVTHSVSYGQDTSF | 1401 | Q8IZF6 | |
| ARSTDTFNYATYHTL | 111 | P15085 | |
| DYVHSFLSSGYSSID | 786 | Q92625 | |
| SSFSSLSNVAYEDDY | 816 | Q9UPM8 | |
| AAAFSSYVGSPYDHT | 76 | P78411 | |
| STSLFSYYNSHDSLS | 571 | Q9Y2R2 | |
| SYAVQSHFGDYNSSI | 151 | P26045 | |
| AYGARHSFSSYSDSF | 351 | P23759 | |
| STRSSQHFYYDGELF | 126 | Q29983 | |
| DYSHSSGVDSAVYFP | 671 | Q8TEW8 | |
| ISTSANLDYEDSSFY | 301 | Q9Y5G7 | |
| SEVEANYHCSLYSSS | 101 | A0A075B6J2 | |
| SASSTYFHQLFSVAG | 51 | Q86T24 | |
| ASTSSTYNFTHYDRI | 596 | Q9NQG7 | |
| IYLFNSSHSDGAQYS | 446 | P0C7V8 | |
| TNSFSYSSYHTLEEI | 131 | Q8WXQ8 | |
| FSLTAEHSGNYYCTA | 436 | Q96RD9 | |
| SFSFSLTEGHSGNYY | 526 | Q96RD9 | |
| SQGSYRDSAYFSDND | 1096 | Q8IWU2 | |
| GDNSDYDYSALSCTS | 6 | Q9UIX4 | |
| YDYSALSCTSDASFH | 11 | Q9UIX4 | |
| QAGSALANYIHFSSY | 216 | Q86V85 | |
| QFYSSASEYHISIAA | 951 | P56199 | |
| YYFSSSGFQADFHEL | 276 | O15529 | |
| SSYHNFYSIRGAEVS | 721 | P78509 | |
| SYRNASSLDSLHYFA | 651 | O14522 | |
| ATSYEDFYLSCSLSH | 646 | O00750 | |
| SASGSLYAVNSFDYE | 526 | Q9Y5I4 | |
| SENGYYLATAADDSS | 401 | Q9UMS4 | |
| YGSALAHFFYSSDQA | 156 | Q8TEZ7 | |
| DFGSATTISHYPDYS | 191 | O14976 | |
| TYDHKNTFTLSYDGS | 1411 | P04114 | |
| LSTYSFATDGFHAAA | 446 | O95677 | |
| TLFDSSYSRNHTYNT | 301 | Q96AY3 | |
| YYLDSTPFAASNHSD | 1136 | Q8N6C5 | |
| SSRNDYIHSGLYSSF | 136 | P28324 | |
| YSSDPESSDYGHVQS | 191 | Q14241 | |
| HTSTLGSVFGDAYYE | 476 | Q6UUV9 | |
| DTGSEHSTAYRFLSY | 206 | A0A1W2PPK0 | |
| SYGSRYSESNFSVDD | 586 | Q5TH69 | |
| QANGLYSTEYIHSSF | 681 | P25067 | |
| SLHGFSSSEDALEYY | 416 | Q9BY84 | |
| DNYHTSFLFGLSTSQ | 511 | Q9BY84 | |
| TESSHFYSASAIYGG | 561 | Q9BY84 | |
| SALSYVYANHFTEAG | 721 | P12111 | |
| YNSTDYFHIDSSSGL | 2331 | Q8TDW7 | |
| YYFSSSGFQADFHEL | 276 | O14843 | |
| SSLNSSSSGDQDYDY | 881 | P55283 | |
| SVSEYHPADGYAFSS | 481 | Q12929 | |
| YAFSSNIYTRGSHLD | 491 | Q12929 | |
| IGDYTDFYSSRQHAT | 121 | P16930 | |
| FSSAESGSSLRYYSE | 91 | Q8NEL9 | |
| SVSHSGESSFTYRAY | 196 | Q99590 | |
| SPSFSSLHYQDAGNY | 376 | Q13740 | |
| SHSFRNTILGYFDYA | 911 | Q01668 | |
| LSYTSSSGDDDFSFY | 91 | Q66K64 | |
| FAFLETYGTHYSSSG | 336 | P02748 | |
| GHSTAYHFLSYNSAE | 236 | A0A1W2PPM1 | |
| SPASQSYSYHSSGEY | 16 | P43354 | |
| SYSYHSSGEYSSDFL | 21 | P43354 | |
| YQRSSSSGSDDYAYT | 501 | Q8N5C8 | |
| ADTSSHFSVDTEGYY | 771 | Q6T4R5 | |
| ASYQSYSSTFHSLEE | 541 | Q3BBV2 | |
| ASYKSYSSTFHSLEE | 576 | P0DPF3 | |
| ASYQSYSSTFHSLEE | 576 | Q6P3W6 | |
| ASYQSYSSTFHSLEE | 576 | Q86T75 | |
| LASYQSYSSTFHSLE | 846 | Q5TAG4 | |
| ASYKSYSSTFHSLEE | 236 | Q5TI25 | |
| ASYKSYSSTFHSLEE | 236 | B4DH59 | |
| SISSIDSTSSYFNHY | 576 | Q13393 | |
| AFSAHSYTSNLGDYD | 291 | A0A0B4J2F2 | |
| AFSAHSYTSNLGDYD | 291 | P57059 | |
| SSSTSDLSNYDHAYL | 196 | Q8TF72 | |
| FASSPRGSEEYYSFH | 206 | Q8NAX2 | |
| HSADDFYAGSTVTYQ | 1701 | Q4LDE5 | |
| YNSDYSGLSHSAFSS | 251 | Q8IXZ3 | |
| DLHSYQSGLIASSYD | 136 | Q96BD0 | |
| KGDFYSYLSLSSHDS | 2106 | Q13023 | |
| GLYSSEYVHSSFSGF | 661 | Q03692 | |
| SSSSQSSHSYKAEEY | 781 | Q9Y2W1 | |
| YHSELSYQESFHSSI | 201 | P0DPA2 | |
| SSDSHSDSFSAFQYD | 906 | Q6GYQ0 | |
| DFLGSSSGYSSEDDY | 126 | Q9UH99 | |
| YTVGSYDSLTSHSDY | 551 | Q9BYB0 | |
| ASSYHSTDADFTGYG | 1401 | Q8NI35 | |
| TVRFHSDQSYTDTGF | 426 | Q9Y5Y6 | |
| SDQSYTDTGFLAEYL | 431 | Q9Y5Y6 | |
| TDTGFLAEYLSYDSS | 436 | Q9Y5Y6 | |
| SSETPGYIYSSNFHA | 646 | Q9BX66 | |
| GSSYSSPDYSLQHFS | 1141 | Q9HBL0 | |
| LYNHSSSEITSLYYD | 2326 | Q6N022 | |
| ASSLSFNFSYGDYDL | 21 | Q8NFJ6 | |
| YYAHTTASTNVSASD | 831 | O14795 | |
| RSHLSGYDYVGFTNS | 2401 | P02549 | |
| AYHSANANSYFSSPT | 431 | Q86WI1 | |
| HAALDDSDFFTSYYT | 286 | Q96AE7 | |
| YNITDHGSLIYSFSE | 421 | P19474 | |
| GHYYSYARNITSTDS | 856 | Q8NB14 | |
| TTDSYGYHSYPLSNS | 736 | Q5HYM0 | |
| SQDGFLSSSTNYYNH | 21 | Q6ZVL8 | |
| FYSVSDGSHLHTYSQ | 431 | Q9Y577 | |
| YECNEYEGSFSHSSD | 436 | Q8N720 | |
| QSGYHSDDTDTTVYS | 1306 | P35968 | |
| NSSEHLFGTSYPYSA | 2646 | Q9BXT5 | |
| GSRHAYSTQSDTSYD | 56 | Q5SRN2 | |
| HNSTSYDSAVIYRGF | 101 | Q6ZP80 | |
| FGYDSFLTQHTSTYT | 381 | Q8WXB4 |